Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Arthritis and CYP3A5[original query] |
|---|
| ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis. Clinica chimica acta; international journal of clinical chemistry 2015 May 445 79-84. Naito Takafumi, Mino Yasuaki, Aoki Yuki, Hirano Kumi, Shimoyama Kumiko, Ogawa Noriyoshi, Kagawa Yoshiyuki, Kawakami Junic |
| Monitoring of peripheral blood cluster of differentiation 4 adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases. Experimental and therapeutic medicine 2018 Jan 15 (1): 532-538. Muraki Yuichi, Mizuno Shugo, Nakatani Kaname, Wakabayashi Hiroki, Ishikawa Eiji, Araki Toshimitsu, Taniguchi Akira, Isaji Shuji, Okuda Masahi |
| Relationships between concomitant biologic DMARDs and prednisolone administration and blood tacrolimus exposure or serum CYP3A4/5-related markers in rheumatoid arthritis patients. Clinical biochemistry 2019 May . Naito Takafumi, Ohshiro Junya, Sato Hikaru, Torikai Eiji, Suzuki Motohiro, Ogawa Noriyoshi, Kawakami Junic |
| CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug metabolism and personalized therapy 2021 3 . Salem Hareedy Mohammad, Rashad Sonya Mohamed, Hetta Helal F, Hassanien Sara Mahmoud, Abdellatif Hebatallah, Hassanien Man |
| Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions. BMC medical genomics 2022 02 15 (1): 23. Gao Beibei, Tan Tingfei, Cao Xi, Pan Menglu, Yang Chunlan, Wang Jianxiong, Shuai Zongwen, Xia Qu |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: